Novo Nordisk CEO on Hims Suit, Wegovy Demand and Pricing

February 11, 2026 at 09:03 PM

By Bloomberg

Novo Nordisk CEO on Hims Suit, Wegovy Demand and Pricing

Advertisement Space - Below Article Title

Novo Nordisk says more than 246,000 people are now taking its weight-loss pill. CEO Mike Doustdar sits down with Bloomberg’s Katie Greifeld to discuss GLP-1 supply, pricing and the company’s lawsuit against Hims over alleged obesity drug copycats. (Source: Bloomberg)

Analysis & Context

Novo Nordisk says more than 246,000 people are now taking its weight-loss pill. CEO Mike Doustdar sits down with Bloomberg’s Katie Greifeld to discuss GLP-1 supply, pricing and the company’s lawsuit against Hims over alleged obesity drug copycats. (Source: Bloomberg) This article provides comprehensive coverage and analysis of current events.

Advertisement Space - In-Article Ad

Novo Nordisk says more than 246,000 people are now taking its weight-loss pill. CEO Mike Doustdar sits down with Bloomberg’s Katie Greifeld to discuss GLP-1 supply, pricing and the company’s lawsuit against Hims over alleged obesity drug copycats. (Source: Bloomberg)

Original Source:

Read full article at source

Advertisement Space - End of Article

Related Articles

Cisco’s stock falls as investors pan a seemingly upbeat earnings report

Cisco’s stock falls as investors pan a seemingly upbeat earnings report

The networking company sported AI momentum and delivered a rosy revenue outlook, but that wasn’t enough for Wall Street.

This iconic American brand’s debt may be on the verge of junk status

A day after Harley-Davidson reported weaker quarterly earnings, the famed motorcycle maker got a warning that its debt ratings may be cut to junk by spring.

Cisco's stock drops 7% on mediocre forecast even as earnings and revenue top estimates

Cisco reported revenue growth in the quarter of close to 10%, topping analysts' estimates.

Difficult to Spot AI Losers: Dudley

Difficult to Spot AI Losers: Dudley

Franklin Templeton Senior Investment Strategist Katrina Dudley discusses the latest jobs report, market broadening and the difficulty in spotting the AI losers versus winners. She speaks to Bloomberg's Matt Miller and Dani Burger on 'Open Interest.' (Source: Bloomberg)

Markets Will Remain Range-Bound: Chiriseri

Markets Will Remain Range-Bound: Chiriseri

Rufaro Chiriseri, UK and Europe Fixed Income Head for RBC Wealth Management, says bond markets will continue to trade in a range until there is better clarity from data. She speaks to Bloomberg's Lizzy Burden on 'Daybreak Europe.' (Source: Bloomberg)

Jobs Pickup Should Give Fed Some Comfort: McKeown

Jobs Pickup Should Give Fed Some Comfort: McKeown

Jennifer McKeown, Chief Global Economist at Capital Economics, looks ahead to the US jobs report and the outlook for rates with Bloomberg's Vonnie Quinn on 'Bloomberg Brief.' (Source: Bloomberg)